Ovarian cancer development program to support new translational projects
Developmental Research Program
['FUNDING_OTHER'] · UNIVERSITY OF TX MD ANDERSON CAN CTR · NIH-11159416
This program funds early-stage projects that aim to create new tests, treatments, or clinical opportunities for people with ovarian cancer.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF TX MD ANDERSON CAN CTR (nih funded) |
| Locations | 1 site (HOUSTON, UNITED STATES) |
| Trial ID | NIH-11159416 on ClinicalTrials.gov |
What this research studies
This program gives seed funding and access to MD Anderson SPORE resources so researchers can move promising ovarian cancer ideas toward patient-focused work. It brings investigators from other fields into ovarian cancer research and encourages collaboration across teams and institutions. Many projects use human tumor samples, clinical data, or patient populations to jump-start translational studies. If you are a patient, you might be invited to donate tissue or participate in specific projects that grow out of this program.
Who could benefit from this research
Good fit: Patients with ovarian cancer or people willing to provide clinical specimens or join research at MD Anderson or partner sites could be involved in projects funded by this program.
Not a fit: People without ovarian cancer or those not enrolled in a specific funded project are unlikely to receive direct benefits from this program.
Why it matters
Potential benefit: If successful, the program could accelerate new diagnostics, therapies, or clinical trials that directly help ovarian cancer patients.
How similar studies have performed: Previous SPORE developmental projects at MD Anderson have supported many investigators and produced substantial publications and follow-on clinical work, so the model has a strong track record.
Where this research is happening
HOUSTON, UNITED STATES
- UNIVERSITY OF TX MD ANDERSON CAN CTR — HOUSTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: BAST, ROBERT C — UNIVERSITY OF TX MD ANDERSON CAN CTR
- Study coordinator: BAST, ROBERT C
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancer Center, Cancers